The Daily Edition

Bailey Flanigan, a young girl from Wisconsin, displayed an insatiable curiosity from a very early age, pursuing an eclectic array of interests ranging from building booby traps to conducting experimental construction projects and exploring medicinal research to writing fiction and music. By high school, she honed in on subjects that allowed her creativity to flourish, such as those involving the application of math to solve real-world problems, creative writing, music, and the exploration of humanities.

Instead of joining clubs, she preferred to spend her time thinking, creating, and delving into what truly captivated her.

In the race for the Golden Boot at the World Cup, Kylian Mbappé of France and Lionel Messi of Argentina are at the forefront. Experts and algorithms alike are debating who will emerge as the top scorer. However, a goldfish named Swimbappé in a Toronto storefront tank may have an edge, as it correctly predicted 14 out of 18 matches, resulting in an accuracy rate of around 80%. This includes the goldfish's ability to call the semifinals and finals accurately.

Google has launched Gemini 3.5 Flash Cyber, a lightweight cybersecurity model designed to quickly and efficiently find, validate, and patch software vulnerabilities. This new model is built on top of Google's existing 3.5 Flash model and is fine-tuned specifically for cybersecurity tasks. By leveraging the cost-efficient and high-capacity performance of 3.5 Flash, Gemini 3.5 Flash Cyber offers a more affordable alternative to larger, pricier cybersecurity models.

Seven biotechnology companies are making waves in the rapidly growing field of mRNA technology. Abogen Biosciences, based in China, is leveraging its mRNA platform to develop synthetic mRNA molecules for use in therapies targeting solid tumors, infectious diseases, and rare diseases. The company's lead candidate, ABO2011, is currently in phase 1/2 trials for solid tumors and shows promise as both a monotherapy and in combination with other treatments.